1. Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. (1st December 2016) Authors: Al‐Sawaf, Othman; Fischer, Kirsten; Herling, Carmen D.; Ritgen, Matthias; Böttcher, Sebastian; Bahlo, Jasmin; Elter, Thomas; Stilgenbauer, Stephan; Eichhorst, Barbara F.; Busch, Raymonde; Elberskirch, Ute; Abenhardt, Wolfgang; Kneba, Michael; Hallek, Michael; Wendtner, Clemens‐Martin Journal: European journal of haematology Issue: Volume 98:Number 3(2017:Mar.) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia. Issue 2 (1st February 2017) Authors: Kutsch, Nadine; Busch, Raymonde; Bahlo, Jasmin; Mayer, Jiri; Hensel, Manfred; Hopfinger, Georg; Hess, Georg; von Grünhagen, Ulrich; Wendtner, Clemens-Martin; Maria Fink, Anna; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara Journal: Leukemia & lymphoma Issue: Volume 58:Issue 2(2017) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Issue 7 (July 2016) Authors: Eichhorst, Barbara; Fink, Anna-Maria; Bahlo, Jasmin; Busch, Raymonde; Kovacs, Gabor; Maurer, Christian; Lange, Elisabeth; Köppler, Hubert; Kiehl, Michael; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Trneny, Marek; F... Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group. Issue 3 (3rd March 2016) Authors: Goede, Valentin; Busch, Raymonde; Bahlo, Jasmin; Chataline, Viktoria; Kremers, Stephan; Müller, Lothar; Reschke, Daniel; Schlag, Rudolf; Schmidt, Burkhard; Vehling-Kaiser, Ursula; Wedding, Ulrich; Stilgenbauer, Stefan; Hallek, Michael Journal: Leukemia & lymphoma Issue: Volume 57:Issue 3(2016:Mar.) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Poor efficacy and tolerability of R‐CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Issue 12 (26th September 2014) Authors: Langerbeins, Petra; Busch, Raymonde; Anheier, Nadine; Dürig, Jan; Bergmann, Manuela; Goebeler, Maria‐Elisabeth; Hurtz, Hans‐Jürgen; Stauch, Martina B.; Stilgenbauer, Stephan; Döhner, Hartmut; Fink, Anna‐Maria; Cramer, Paula; Fischer, Kirsten; Wendtner, Clemens‐Martin; Hallek, Michael; Eichhorst, ... Journal: American journal of hematology Issue: Volume 89:Issue 12(2014:Dec.) Page Start: E239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. Issue 7 (4th May 2007) Authors: Gamboa-Dominguez, Armando; Seidl, Stefan; Reyes-Gutierrez, Edgardo; Hermannstädter, Christine; Quintanilla-Martinez, Leticia; Busch, Raymonde; Höfler, Heinz; Fend, Falko; Luber, Birgit Journal: Journal of clinical pathology Issue: Volume 60:Issue 7(2007) Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group. Issue 8 (August 2013) Authors: Cramer, Paula; Fink, Anna-Maria; Busch, Raymonde; Eichhorst, Barbara; Wendtner, Clemens-Martin; Pflug, Natali; Langerbeins, Petra; Bahlo, Jasmin; Goede, Valentin; Schubert, Friederike; Döhner, Hartmut; Stilgenbauer, Stephan; Dreger, Peter; Kneba, Michael; Böttcher, Sebastian; Mayer, Jiri; Hallek,... Journal: Leukemia & lymphoma Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T‐cell prolymphocytic leukemia. Issue 12 (19th March 2013) Authors: Hopfinger, Georg; Busch, Raymonde; Pflug, Natali; Weit, Nicole; Westermann, Anne; Fink, Anna‐Maria; Cramer, Paula; Reinart, Nina; Winkler, Dirk; Fingerle‐Rowson, Günter; Stilgenbauer, Stephan; Döhner, Hartmut; Kandler, Gabriele; Eichhorst, Barbara; Hallek, Michael; Herling, Marco Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T‐cell prolymphocytic leukemia. Issue 12 (19th March 2013) Authors: Hopfinger, Georg; Busch, Raymonde; Pflug, Natali; Weit, Nicole; Westermann, Anne; Fink, Anna‐Maria; Cramer, Paula; Reinart, Nina; Winkler, Dirk; Fingerle‐Rowson, Günter; Stilgenbauer, Stephan; Döhner, Hartmut; Kandler, Gabriele; Eichhorst, Barbara; Hallek, Michael; Herling, Marco Journal: Cancer Issue: Volume 119:Issue 12(2013) Page Start: 2258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗